This is the first book to address the needs of theever-increasing population of long term survivors after stemcell transplantation. The book will focus on
- how to follow up long term survivors after stem celltransplantation: preventing late deaths from transplant relatedcomplication and improving quality of life
- long term follow-up after stem cell transplantation: anunmet need in the literature, a growing field in medicine.
- remedies for primary care providers, oncologists,hematologists, transplant providers
This will be a multi-contributed book. Late effects [after stemcell transplantation] experts from across the globe will be invitedto write chapters (numbers of contributing authors around 20).
|Product dimensions:||7.30(w) x 9.80(h) x 1.00(d)|
About the Author
Edited by Bipin N Savani Professor of Medicine, Director, Long Term Transplant Clinic, Hematology and Stem Cell Transplantation Section, Vanderbilt University Medical Center, Nashville, TN, USA
Table of Contents
Foreword by John Barrett viiForeword by Stephanie J Lee viiiForeword by John Goldman ixList of Contributors xSection 1 Late effects concepts 11 Introduction 3Bipin N Savani2 Overview: transplant data and increasing numbers of long-termsurvivors 7Jakob R Passweg and Helen Baldomero3 Long-term transplant clinic setup 11André Tichelli, Joerg P Halter, Jakob R Passweg, and AliciaRovó4 Late effects after allogeneic hematopoietic stem celltransplantation 21Shahrukh Hashmi and Mark R Litzow5 Late effects after autologous hematopoietic stem celltransplantation 31Sairah Ahmed and Yago Nieto6 Graft-versus-host disease and late effects after hematopoeticstem cell transplantation 43Gérard Socié7 Prominent role of allied health professionals (nursepractitioners, physician assistants, others) in long-term follow-upafter hematopoietic stem cell transplantation 52Catherine E LucidSection 2 Management, 558 Screening and prevention guidelines for hematopoietic celltransplant survivors 57Navneet S Majhail and J Douglas Rizzo9 Secondary malignancies: prevalence, screening, prevention, andmanagement guidelines 65Paolo F Caimi and Hillard M Lazarus10 Cutaneous chronic graft-versus-host disease 77Attilio Olivieri, Daniela Massi, Andrea Bacigalupo, and AnnaCampanati11 Anti-infective prophylaxis, immunization and prevention ofrecurrent infectious complications in long-term survivors 106John P Galvin and Jayesh Mehta12 Seasonal virus infections: prevention and management guidelines116Gaurav Trikha and John R Wingard13 Exposure to family members: infections and recent livevaccinations 130Brian G Engelhardt and James E Crowe, Jr14 Late pulmonary complications after allogeneic hematopietic stemcell transplantion: bronchiolitisobliterans syndrome (BOS) and organizing pneumonia (OP) 141Lee Gazourian, Gerald L Weinhouse, Joseph H Antin, and Vincent THo15 Post-transplantation bone disease: prevalence, monitoring,prevention, and management guidelines 151Kathryn Dahir, Brandon Perry, and Shubhada Jagasia16 Ocular complications: prevalence, monitoring, prevention, andmanagement guidelines 162André Tichelli and Alicia Rovó17 Oral complications in hematopoietic stem cell transplantationsurvivorship 172Sharon Elad, Corey Cutler, and Nathaniel Treister18 Sexual dysfunction in long-term survivors: monitoring andmanagement 183Andrea L Utz and Shubhada Jagasia19 Fertility issues, contraception, and pregnancy outcome inlong-term survivors 193Alicia Rovó, Nina Salooja, Carl P Schwarze, Joerg P Halter,and André Tichelli20 Follow-up of children after hematopoietic stem celltransplantation: growth and development 203Kristina K Hardy, David A Jacobsohn, and EvelioPerez-Albuerne21 Posttransplant diabetes mellitus: monitoring, prevention, andmanagement guidelines 215Prathima Jasti, Shichun Bao, and Shubhada Jagasia22 Thyroid disease: monitoring and management guidelines 225M Kathleen Figaro, Cheryl A Fassler, Shubhada Jagasia, and VipulT Lakhani23 Special issues related to female long-term survivors 233Melissa A Merideth, Kristin Clay Chabarria, Tajana KlepacPulanic, and Pamela Stratton24 Cardiac and vascular complications in long-term survivors afterhematopoietic stem cell transplantation 244Alicia Rovó and André Tichelli25 Hyperlipidemia: prevalence, monitoring, management, interactionswith immunosuppressive agents, and follow-up 258Dara L Eckerle Mize, Shubhada Jagasia, and Jeffrey BBoord26 Hypertension management in long-term survivors 269Imad Abboud27 Gastrointestinal complications of hematopoietic celltransplantation 276Preet Bagi, Niharika Samala, Steven Pavletic, and TheoHeller28 Hepatic complications of hematopoietic stem cell transplantation286Niharika Samala, Preet Bagi, Theo Heller, and StevenPavletic29 Monitoring and management of hepatitis B, hepatitis C, and HIVinfection before and after transplantation 294Keith Luckett and Stephen Dummer30 Prevention and management of renal complications in long-termsurvivors 304Michael Dickenmann and Joerg P Halter31 Immunosuppressive agents and monitoring in long-term survivors314Paul Shaughnessy and Helen LeatherSection 3 Supportive care for long-term survivors after HSCT32132 Nutritional assessments and nutritional supplementation forlong-term transplant survivors: multivitamins, vitamin D, calcium,antioxidants, and minerals 323Lauren Zatarain, LaQuisa Hill, Daniel R Thomas, and Stacey AGoodman33 Daily routines and guidelines: driving, infection isolation,masks, food/diet, activities, exercise, pets, sun exposures, andothers 332Angela M Woods34 Caregivers of long-term survivors 340Elizabeth Wulff-Burchfield35 Health-related quality of life in adult and pediatric survivorsof hematopoietic stem cell transplantation 345Margaret Bevans and Lori Wiener36 Prevalent psychosocial adjustment issues and solutions:lifestyle and social challenges 368Katrina M Stokes37 A patient’s perspective: concepts of long-term survivorsupport groups and their roles 376Michael W BrownAPPENDIX 1 NMDP/Be The Match posttransplant guidelines resources379Darlene HavenAPPENDIX 2 Long-term follow-up calendar 381André Tichelli, Joerg P Halter, Jakob R Passweg, and AliciaRovóAPPENDIX 3 Commonly used transplant-related medications inlong-term survivors 385Melissa LogueIndex, 387